Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2023 | 1 |
2024 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Did you mean
zulfiqar s[au]
(110 results)?
Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UK.
ERJ Open Res. 2024 Jan 15;10(1):00529-2023. doi: 10.1183/23120541.00529-2023. eCollection 2024 Jan.
ERJ Open Res. 2024.
PMID: 38226064
Free PMC article.
The Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitor Empagliflozin Reverses Hyperglycemia-Induced Monocyte and Endothelial Dysfunction Primarily through Glucose Transport-Independent but Redox-Dependent Mechanisms.
Semo D, Obergassel J, Dorenkamp M, Hemling P, Strutz J, Hiden U, Müller N, Müller UA, Zulfikar SA, Godfrey R, Waltenberger J.
Semo D, et al. Among authors: zulfikar sa.
J Clin Med. 2023 Feb 8;12(4):1356. doi: 10.3390/jcm12041356.
J Clin Med. 2023.
PMID: 36835891
Free PMC article.
Item in Clipboard
Inhibitors of the Autotaxin-Lysophosphatidic Acid Axis and Their Potential in the Treatment of Interstitial Lung Disease: Current Perspectives.
Zulfikar S, Mulholland S, Adamali H, Barratt SL.
Zulfikar S, et al.
Clin Pharmacol. 2020 Jul 13;12:97-108. doi: 10.2147/CPAA.S228362. eCollection 2020.
Clin Pharmacol. 2020.
PMID: 32765123
Free PMC article.
Review.
Item in Clipboard
Cite
Cite